Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
LeMaitre Vascular (NASDAQ:LMAT) reported its Q4 earnings results on Tuesday, February 27, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
LeMaitre Vascular beat estimated earnings by 6.0%, reporting an EPS of $0.38 versus an estimate of $0.36.
Revenue was up $7.93 million from the same period last year.
Last quarter the company beat on EPS by $0.03 which was followed by a 2.0% drop in the share price the next day.
Here's a look at LeMaitre Vascular's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | 0.30 | 0.32 | 0.25 | 0.26 |
EPS Actual | 0.33 | 0.37 | 0.27 | 0.25 |
Revenue Estimate | 47.59M | 48.29M | 43.54M | 40.99M |
Revenue Actual | 47.41M | 50.12M | 47.08M | 40.95M |
To track all earnings releases for LeMaitre Vascular visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: LMAT